Biomerica (BMRA) Income from Non-Controlling Interests (2017)
Biomerica (BMRA) posted Income from Non-Controlling Interests of $680893.0 for Q2 2017.
Biomerica (BMRA) Income from Non-Controlling Interests (2017) Analysis & Trends
Biomerica has reported Income from Non-Controlling Interests for 1 years, with the latest figure at $680893.0 in Q2 2017.
- Quarterly Income from Non-Controlling Interests changed N/A year-over-year to $680893.0 in Q2 2017, while the trailing twelve-month figure through May 2017 was $680893.0 (changed N/A YoY) and the FY2021 annual result came in at $936615.0, changed N/A from the prior year.
- Income from Non-Controlling Interests was little changed at $680893.0 in Q2 2017 per BMRA's latest filing.
- Over five years, Income from Non-Controlling Interests peaked at $680893.0 in Q2 2017 and troughed at $680893.0 in Q2 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.81 Bn | 193.21 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.76 Bn | 124.28 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 16.00 Mn |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | -500,000.00 |
| 6 | Dexcom | 34.43 Bn | 32.49 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.88 Bn | 31.77 Bn | 2.18 Bn | 13.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 2.32 Mn |
| 9 | Steris | 23.11 Bn | 22.63 Bn | 684.20 Mn | 900,000.00 |
| 10 | Biomerica | 4.58 Mn | 3.24 Mn | -44,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2017 | 680,893.00 |